CHOICE: CHOosing treatment together In Cancer at the End of life
Completed
- Conditions
- advanced cancermetastasized or inoperable tumours
- Registration Number
- NL-OMON22913
- Lead Sponsor
- Academic Medical Center, University of Amsterdam
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 192
Inclusion Criteria
Patients
In order to be eligible to participate in this study, a subject must meet all of the following criteria:
Exclusion Criteria
Patients
A potential subject who meets any of the following criteria will be excluded from participation in this study:
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Observed SDM in the audio-recorded consultation as assessed with a validated scoring instrument (OPTION) as well as a study-specific adaptation of that instrument.
- Secondary Outcome Measures
Name Time Method a. Observed SDM in a simulated patient encounter (effect training only)<br /><br>b. Patients’ perceived efficacy in communication<br /><br>c. Patient and oncologist satisfaction with communication and decision making<br /><br>d. Congruence between patients’ preferred and perceived role in decision making<br /><br>e. Patients’ attitudes towards striving for quantity (length) or quality of life<br /><br>f. Patients’ evaluation of the decision made<br /><br>g. Patients’ quality of life<br /><br>h. The treatment decision made<br /><br>i. Patients’ trust in the oncologist<br /><br>j. Patients’ anxiety<br /><br>k. Patients’ fighting spirit<br /><br>l. Consultation time<br /><br>m. Patients'use and evaluation of the ‘Gesprekswijzer’<br><br>